Product record
Ridtas S Amlodipine: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
2 batches of products named "Ridtas S Amlodipine" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between December 2022 and February 2023. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
2 records linked to Ridtas S Amlodipine in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| RT220619Mfg 2022-08 · Exp 2024-07 | Ridley Lifesciences Pvt. LtdDelhi | Dissolution & Assay of S (-) AmlodipineAssay | CDL KolkataCDSCO lab | Feb 2023 |
| RT220619Mfg 2022-08 · Exp 2024-07 | Ridley Life Sciences Pvt. LtdDelhi | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Dec 2022 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.